Logo image of EMN.CA

EURO MANGANESE INC (EMN.CA) Stock Fundamental Analysis

TSX-V:EMN - TSX Venture Exchange - CA29872T2092 - Common Stock - Currency: CAD

0.175  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to EMN. EMN was compared to 808 industry peers in the Metals & Mining industry. Both the profitability and financial health of EMN have multiple concerns. EMN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

EMN had negative earnings in the past year.
EMN had a negative operating cash flow in the past year.
In the past 5 years EMN always reported negative net income.
In the past 5 years EMN always reported negative operating cash flow.
EMN.CA Yearly Net Income VS EBIT VS OCF VS FCFEMN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

EMN has a Return On Assets of -57.72%. This is in the lower half of the industry: EMN underperforms 65.97% of its industry peers.
Industry RankSector Rank
ROA -57.72%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMN.CA Yearly ROA, ROE, ROICEMN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

EMN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMN.CA Yearly Profit, Operating, Gross MarginsEMN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

2

2. Health

2.1 Basic Checks

EMN does not have a ROIC to compare to the WACC, probably because it is not profitable.
EMN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EMN.CA Yearly Shares OutstandingEMN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
EMN.CA Yearly Total Debt VS Total AssetsEMN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -4.36, we must say that EMN is in the distress zone and has some risk of bankruptcy.
EMN has a Altman-Z score of -4.36. This is in the lower half of the industry: EMN underperforms 64.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.36
ROIC/WACCN/A
WACC7.86%
EMN.CA Yearly LT Debt VS Equity VS FCFEMN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

EMN has a Current Ratio of 1.27. This is a normal value and indicates that EMN is financially healthy and should not expect problems in meeting its short term obligations.
EMN has a Current ratio (1.27) which is comparable to the rest of the industry.
A Quick Ratio of 1.02 indicates that EMN should not have too much problems paying its short term obligations.
EMN has a Quick ratio (1.02) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.02
EMN.CA Yearly Current Assets VS Current LiabilitesEMN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

1

3. Growth

3.1 Past

The earnings per share for EMN have decreased strongly by -44.81% in the last year.
The Revenue has grown by 228.28% in the past year. This is a very strong growth!
EPS 1Y (TTM)-44.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.14%
Revenue 1Y (TTM)228.28%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMN.CA Yearly Revenue VS EstimatesEMN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 1M 2M 3M
EMN.CA Yearly EPS VS EstimatesEMN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2021 2022 2023 2024 -0.1 -0.2 -0.3

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EMN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMN.CA Price Earnings VS Forward Price EarningsEMN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMN.CA Per share dataEMN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EMN!.
Industry RankSector Rank
Dividend Yield N/A

EURO MANGANESE INC

TSX-V:EMN (7/4/2025, 7:00:00 PM)

0.175

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-12 2025-08-12
Inst Owners31.11%
Inst Owner ChangeN/A
Ins Owners1.53%
Ins Owner ChangeN/A
Market Cap14.09M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.58
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0.05
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -57.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 83.63%
Cap/Sales 86.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.02
Altman-Z -4.36
F-Score3
WACC7.86%
ROIC/WACCN/A
Cap/Depr(3y)888.95%
Cap/Depr(5y)944.68%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)228.28%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.8%
OCF growth 3YN/A
OCF growth 5YN/A